Simultaneous determination of the lactone and carboxylate forms of the camptothecin derivative CPT-11 and its metabolite SN-38 in plasma by high-performance liquid chromatography

被引:51
作者
Chollet, DF
Goumaz, L
Renard, A
Montay, G
Vernillet, L
Arnera, V
Mazzo, DJ
机构
[1] COVANCE Cent Lab Serv SA, CH-1217 Geneva, Switzerland
[2] Rhone Poulenc Rorer, Drug Metab & Pharmacokinet Dept, F-94403 Vitry, France
[3] Rhone Poulenc Rorer, Drug Metab & Pharmacokinet Dept, F-92165 Antony, France
来源
JOURNAL OF CHROMATOGRAPHY B | 1998年 / 718卷 / 01期
关键词
irinotecan; CPT-11; SN-38; camptothecin;
D O I
10.1016/S0378-4347(98)00270-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
CPT-11 (irinotecan) and mainly its metabolite SN-38 are potent antitumor derivatives of camptothecin. As the active lactone forms of both CPT-11 and SN-38 exist in ps-dependent equilibrium with their respective less potent open-ring hydroxy acid species, the simultaneous monitoring of both forms of both compounds is relevant. CPT-11 and SN-38 derivatives have quite different fluorescence responses. In order to avoid any compromise on the wavelength setting, we developed chromatographic conditions allowing simple automated wavelength setting changes which have been prevented using existing methods involving conventional C-18 columns. This was achieved by means of a Symmetry C-18 column combined to a gradient elution program using acetonitrile and 75 mM ammonium acetate plus 7.5 mM tetrabutylammonium bromide at pH 6.4. The developed conditions allowed an elution order suitable for a simple automated wavelength change in respect to reliable peak integration. CPT-11 and SN-38 derivatives were detected at lambda(ex) = 362 nm/lambda(em) = 425 nm and lambda(ex) = 375 nm/lambda(em) = 560 nn, respectively. The developed method allowed the detection of amounts less than 3 pg of each derivative injected on column. The method was successfully applied to pharmacokinetic and toxicokinetic studies in rat and dog. (C) 1998 Elsevier Science BN. All rights reserved.
引用
收藏
页码:163 / 175
页数:13
相关论文
共 29 条
[1]   Simultaneous determination of a camptothecin derivative, used as an anticancer drug, and its photodegradation products by high-performance liquid chromatography [J].
Akimoto, K ;
Kawai, A ;
Ohya, K .
JOURNAL OF CHROMATOGRAPHY A, 1996, 734 (02) :401-404
[2]   SELECTIVE AND SENSITIVE DETERMINATION OF LACTONE AND HYDROXY ACID FORMS OF CAMPTOTHECIN AND 2 DERIVATIVES (CPT-11 AND SN-38) BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
AKIMOTO, K ;
GOTO, A ;
OHYA, K .
JOURNAL OF CHROMATOGRAPHY, 1991, 588 (1-2) :165-170
[3]   SIMULTANEOUS DETERMINATION OF THE CAMPTOTHECIN ANALOG CPT-11 AND ITS ACTIVE METABOLITE SN-38 BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY - APPLICATION TO PLASMA PHARMACOKINETIC STUDIES IN CANCER-PATIENTS [J].
BARILERO, I ;
GANDIA, D ;
ARMAND, JP ;
MATHIEUBOUE, A ;
RE, M ;
GOUYETTE, A ;
CHABOT, GG .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 575 (02) :275-280
[4]   Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice [J].
Bissery, MC ;
Vrignaud, P ;
Lavelle, F ;
Chabot, GG .
ANTI-CANCER DRUGS, 1996, 7 (04) :437-460
[5]   THE IMPORTANT ROLE OF ALBUMIN IN DETERMINING THE RELATIVE HUMAN BLOOD STABILITIES OF THE CAMPTOTHECIN ANTICANCER DRUGS [J].
BURKE, TG ;
MUNSHI, CB ;
MI, ZH ;
JIANG, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) :518-519
[6]   PREFERENTIAL BINDING OF THE CARBOXYLATE FORM OF CAMPTOTHECIN BY HUMAN SERUM-ALBUMIN [J].
BURKE, TG ;
MI, ZH .
ANALYTICAL BIOCHEMISTRY, 1993, 212 (01) :285-287
[7]   Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detection [J].
deBruijn, P ;
Verweij, J ;
Loos, WJ ;
Nooter, K ;
Stoter, G ;
Sparreboom, A .
JOURNAL OF CHROMATOGRAPHY B, 1997, 698 (1-2) :277-285
[8]   A KINETIC AND MECHANISTIC STUDY OF THE HYDROLYSIS OF CAMPTOTHECIN AND SOME ANALOGS [J].
FASSBERG, J ;
STELLA, VJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (07) :676-684
[9]  
HAKUSUI H, DAICHI PHARM
[10]  
Hidetaka S., 1995, J CHROMATOGR, V670, P309